AwesomeCapital
Search This Blog
Thursday, August 1, 2019
CRISPR Therapeutics started at Buy by Jefferies
Target $64
https://www.benzinga.com/stock/CRSP/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.